Background Increasing access to and targeting of artemisinin-based combination therapy
(ACT) is a key component of malaria control programmes. To maximize efficacy of ACT and …

Universal access to healthcare, including quality medicines, is a fundamental human right
but is still out of reach for many in low-and middle-income countries (LMICs). An existing …

Background Malaria treatment policy recommends regular monitoring of drug utilization to
generate information for ensuring effective use of anti-malarial drugs in Nigeria. This …

Background Malaria case management relies on World Health Organization (WHO)-
recommended artemisinin-based combination therapy (ACT), and a continuous …

Background Prompt and appropriate treatment of malaria with effective medicines remains
necessary if malaria control goals are to be achieved. The theoretical concepts from self …

Background Artemisinin-based combination therapy (ACT) has been adopted as the most
effective treatment against malaria in many endemic countries like Kenya while quinine has …

The Plasmodium parasite is a eukaryotic unicellular pathogen and the causative agent of
the tropical disease malaria. Malaria is caused by five species of the genus Plasmodium that …

Background Studies assessing consumers' knowledge of the rational use of antibiotics are
essential to understand the knowledge gap before intervention strategies are instituted …

Background Malaria remains a global health issue with the burden unevenly distributed to
the disadvantage of the developing countries of the world. Poverty contributes to the malaria …

Introduction.“Health for All” still eludes public health experts despite many approaches to
prevent disease and promote health among urban poor. Several key illness factors lie …